Report Summary
Eternity Insights has published a new study on Global Dry Powder Inhaler Market focusing on key segments as by Type (Single Dose Dry Powder Inhaler, Multi Dose Dry Powder Inhaler, Other), by Application (Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Dry Powder Inhaler Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Dry Powder Inhaler Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Dry Powder Inhaler Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Dry Powder Inhaler Market Segmentation:
Dry Powder Inhaler Market, By Type
- Single Dose Dry Powder Inhaler
- Multi Dose Dry Powder Inhaler
- Other
Dry Powder Inhaler Market, By Application
- Asthma
- Chronic Obstructive Pulmonary Disease
- Pulmonary Arterial Hypertension
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Dry Powder Inhaler market in terms of demand generation. The Dry Powder Inhaler market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Dry Powder Inhaler market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Dry Powder Inhaler Market Taxonomy:
To learn more about this report
Global Dry Powder Inhaler Market Competitive Landscape
The global Dry Powder Inhaler market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Astrazeneca
- 3M
- GlaxoSmithKline
- Novartis
- Cipla
- Teva
- Boehringer Ingelheim
- Chiesi Farmaceutici
- MannKind
- Vectura
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Single Dose Dry Powder Inhaler, Multi Dose Dry Powder Inhaler, Other |
| By Application Outlook |
Asthma, Chronic Obstructive Pulmonary Disease, Pulmonary Arterial Hypertension, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Astrazeneca, 3M, GlaxoSmithKline, Novartis, Cipla, Teva, Boehringer Ingelheim, Chiesi Farmaceutici, MannKind, Vectura |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Dry Powder Inhaler Market Overview
1.1 Dry Powder Inhaler Product Overview
1.2 Dry Powder Inhaler Market Segment by Type
1.2.1 Single Dose Dry Powder Inhaler
1.2.2 Multi Dose Dry Powder Inhaler
1.3 Global Dry Powder Inhaler Market Size by Type
1.3.1 Global Dry Powder Inhaler Sales and Growth by Type
1.3.2 Global Dry Powder Inhaler Sales and Market Share by Type (2017-2020)
1.3.3 Global Dry Powder Inhaler Revenue and Market Share by Type (2017-2020)
1.3.4 Global Dry Powder Inhaler Price by Type (2017-2020)
2 Global Dry Powder Inhaler Market Competition by Company
2.1 Global Dry Powder Inhaler Sales and Market Share by Company (2017-2020)
2.2 Global Dry Powder Inhaler Revenue and Share by Company (2017-2020)
2.3 Global Dry Powder Inhaler Price by Company (2017-2020)
2.4 Global Top Players Dry Powder Inhaler Manufacturing Base Distribution, Sales Area, Product Types
2.5 Dry Powder Inhaler Market Competitive Situation and Trends
2.5.1 Dry Powder Inhaler Market Concentration Rate
2.5.2 Global Dry Powder Inhaler Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Dry Powder Inhaler Company Profiles and Sales Data
3.1 Astrazeneca
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Dry Powder Inhaler Product Category, Application and Specification
3.1.3 Astrazeneca Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.1.4 Main Business Overview
3.2 3M
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Dry Powder Inhaler Product Category, Application and Specification
3.2.3 3M Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.2.4 Main Business Overview
3.3 GlaxoSmithKline
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Dry Powder Inhaler Product Category, Application and Specification
3.3.3 GlaxoSmithKline Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.3.4 Main Business Overview
3.4 Novartis
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Dry Powder Inhaler Product Category, Application and Specification
3.4.3 Novartis Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.4.4 Main Business Overview
3.5 Cipla
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Dry Powder Inhaler Product Category, Application and Specification
3.5.3 Cipla Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.5.4 Main Business Overview
3.6 Teva
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Dry Powder Inhaler Product Category, Application and Specification
3.6.3 Teva Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.6.4 Main Business Overview
3.7 Boehringer Ingelheim
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Dry Powder Inhaler Product Category, Application and Specification
3.7.3 Boehringer Ingelheim Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.7.4 Main Business Overview
3.8 Chiesi Farmaceutici
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Dry Powder Inhaler Product Category, Application and Specification
3.8.3 Chiesi Farmaceutici Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.8.4 Main Business Overview
3.9 MannKind
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Dry Powder Inhaler Product Category, Application and Specification
3.9.3 MannKind Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.9.4 Main Business Overview
3.10 Vectura
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Dry Powder Inhaler Product Category, Application and Specification
3.10.3 Vectura Dry Powder Inhaler Sales, Revenue, Price and Gross Margin(2017-2020)
3.10.4 Main Business Overview
4 Dry Powder Inhaler Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Dry Powder Inhaler Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Dry Powder Inhaler Sales and Revenue by Regions
4.2.1 Global Dry Powder Inhaler Sales and Market Share by Regions (2017-2020)
4.2.2 Global Dry Powder Inhaler Revenue and Market Share by Regions (2017-2020)
4.2.3 Global Dry Powder Inhaler Sales, Revenue, Price and Gross Margin (2017-2020)
4.3 North America Dry Powder Inhaler Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Dry Powder Inhaler Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Dry Powder Inhaler Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Dry Powder Inhaler Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Dry Powder Inhaler Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Dry Powder Inhaler Application/End Users
5.1 Dry Powder Inhaler Segment by Application
5.1.1 Asthma
5.1.2 Chronic Obstructive Pulmonary Disease
5.1.3 Pulmonary Arterial Hypertension
5.1.4 Others
5.2 Global Dry Powder Inhaler Product Segment by Application
5.2.1 Global Dry Powder Inhaler Sales by Application
5.2.2 Global Dry Powder Inhaler Sales and Market Share by Application (2017-2020)
6 Global Dry Powder Inhaler Market Forecast
6.1 Global Dry Powder Inhaler Sales, Revenue Forecast (2021-2027)
6.1.1 Global Dry Powder Inhaler Sales and Growth Rate Forecast (2021-2027)
6.1.1 Global Dry Powder Inhaler Revenue and Growth Rate Forecast (2021-2027)
6.2 Global Dry Powder Inhaler Forecast by Regions
6.2.1 North America Dry Powder Inhaler Sales and Revenue Forecast (2021-2027)
6.2.2 Europe Dry Powder Inhaler Sales and Revenue Forecast (2021-2027)
6.2.3 Asia-Pacific Dry Powder Inhaler Sales and Revenue Forecast (2021-2027)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Dry Powder Inhaler Sales and Revenue Forecast (2021-2027)
6.2.5 Middle East and Africa Dry Powder Inhaler Sales and Revenue Forecast (2021-2027)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Dry Powder Inhaler Forecast by Type
6.3.1 Global Dry Powder Inhaler Sales and Revenue Forecast by Type (2021-2027)
6.3.2 Single Dose Dry Powder Inhaler Gowth Forecast
6.3.3 Multi Dose Dry Powder Inhaler Gowth Forecast
6.4 Dry Powder Inhaler Forecast by Application
6.4.1 Global Dry Powder Inhaler Sales Forecast by Application (2021-2027)
6.4.2 Global Dry Powder Inhaler Forecast in Asthma
6.4.3 Global Dry Powder Inhaler Forecast in Chronic Obstructive Pulmonary Disease
7 Dry Powder Inhaler Upstream Raw Materials
7.1 Dry Powder Inhaler Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Dry Powder Inhaler Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
